BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 22, Issue 4
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (16775)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.
Item 
Count 
PDF1405
WORD492
HTML9129
Figures (1-1)460
Tables (1-2)424
 Sum=11910
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse504
Download1092
 Sum=1596
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1538
Download1731
 Sum=3269
Jan 28, 2016 (publication date) through Jul 5, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Ress C, Kaser S. Mechanisms of intrahepatic triglyceride accumulation. World J Gastroenterol 2016; 22(4): 1664-1673 [PMID: 26819531 DOI: 10.3748/wjg.v22.i4.1664]
URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1664.htm
Number Citing Articles
1
Yusuke Sasaki, Masato Asahiyama, Toshiya Tanaka, Shogo Yamamoto, Kentaro Murakami, Wakana Kamiya, Yoshihiro Matsumura, Tsuyoshi Osawa, Motonobu Anai, Jean-Charles Fruchart, Hiroyuki Aburatani, Juro Sakai, Tatsuhiko Kodama. Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-64902-8
2
Preethi Chandrasekaran, Ralf Weiskirchen. The signaling pathways in obesity‐related complications. Journal of Cell Communication and Signaling 2024; 18(2) doi: 10.1002/ccs3.12039
3
Soo Jin Lee, Woo-Cheol Shin, Sangmin Ju, Mi-Ri Gwon, Jae-Hwa Lee, Young-Ran Yoon, Stuart K. Calderwood, Dae Young Lee, Heeyoun Bunch. Jerusalem artichoke extracts regulate the gene expression of key enzymes involved in fatty acid biosynthesis. Journal of Agriculture and Food Research 2025; 21: 101819 doi: 10.1016/j.jafr.2025.101819
4
Takanobu Iwadare, Takefumi Kimura, Hideo Kunimoto, Taiki Okumura, Shun-Ichi Wakabayashi, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Naoki Tanaka, Takeji Umemura. Long-Term pemafibrate treatment exhibits limited impact on body fat mass in patients with hypertriglyceridemia accompanying NAFLD. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1329294
5
Prajakta C. Shimpi, Vijay R. More, Maneesha Paranjpe, Ajay C. Donepudi, Jaclyn M. Goodrich, Dana C. Dolinoy, Beverly Rubin, Angela L. Slitt. Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver Disease. Environmental Health Perspectives 2017; 125(8) doi: 10.1289/EHP664
6
Kyoko Oura, Asahiro Morishita, Joji Tani, Tsutomu Masaki. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 1279 doi: 10.2147/JHC.S392051
7
Yan Deng, Xiaoming Liu, Yuzhe Sun, Li Zhou, Qiang Li, Ziqiao Lei, Fan Yang, Liangkai Chen, Chen Zhang, Wei Tan, Xin Jin, Zhuang Han, Huiyang Xu, Qing Wang, Qi Nie, Haoran Yi, Wei Bao, Shuang Rong. Effects of time‐restricted eating on intrahepatic fat and metabolic health among patients with nonalcoholic fatty liver disease. Obesity 2024; 32(3): 494 doi: 10.1002/oby.23965
8
Emmanuelle Berger, Alain Géloën. Adipocytes as lipid sensors of oleic acid transport through a functional Caco-2/HT29-MTX intestinal barrier. Adipocyte 2019; 8(1): 83 doi: 10.1080/21623945.2019.1580842
9
Fita Nur Jannah, Putri Diyah Anggraini, Abdul Gofur, Sri Rahayu Lestari. The prevention of single bulb garlic extract on non-alcoholic fatty liver disease (NAFLD) in high fat mice (Mus musculus) model. INTERNATIONAL CONFERENCE ON LIFE SCIENCES AND TECHNOLOGY (ICoLiST 2020) 2021; 2353: 030095 doi: 10.1063/5.0052672
10
Mugdha V. Padalkar, Alexandra H. Tsivitis, Ylona Gelfman, Mariya Kasiyanyk, Neil Kaungumpillil, Danyang Ma, Michael Gao, Kelly A. Borges, Puneet Dhaliwal, Saud Nasruddin, Sruthi Saji, Hina Gilani, Eric J. Schram, Mohnish Singh, Maria M. Plummer, Olga V. Savinova. Paradoxical reduction of plasma lipids and atherosclerosis in mice with adenine-induced chronic kidney disease and hypercholesterolemia. Frontiers in Cardiovascular Medicine 2023; 10 doi: 10.3389/fcvm.2023.1088015
11
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
12
VIKTOR TOMCHUK, ANDRII POTOTSKYI, VIKTORIIA GRYSHCHENKO, STANISLAV VESELSKYI, YEVDOKIIA RESHETNIK. CORRECTION OF TRIACYLGLYCEROLS AND FREE FATTY ACIDS IN RAT BILE IN EXPERIMENTAL HEPATIC STEATOSIS. Ukrainian journal of veterinary sciences 2022; 13(2) doi: 10.31548/ujvs.13(2).2022.53-62
13
Yu Yuan Li, Dan Tang, Yan Lei Du, Chuang Yu Cao, Yu Qiang Nie, Jie Cao, Yong Jian Zhou. Fatty liver mediated by peroxisome proliferator‐activated receptor‐α DNA methylation can be reversed by a methylation inhibitor and curcumin. Journal of Digestive Diseases 2018; 19(7): 421 doi: 10.1111/1751-2980.12610
14
Jae Seok Bae, Dong Ho Lee, Kyung-Suk Suh, Haeryoung Kim, Kyung Bun Lee, Jae Young Lee, Joon Koo Han. Noninvasive assessment of hepatic steatosis using a pathologic reference standard: comparison of CT, MRI, and US-based techniques. Ultrasonography 2022; 41(2): 344 doi: 10.14366/usg.21150
15
Yichao Wang, Hang Zhao, Liying Yang, He Zhang, Xian Yu, Wenjie Fei, Yunfeng Zhen, Zhe Gao, Shuchun Chen, Luping Ren. Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice. Bioengineered 2022; 13(3): 6750 doi: 10.1080/21655979.2022.2045837
16
Meg Schuurman, Madison Wallace, Gurleen Sahi, Malina Barillaro, Siyi Zhang, Mushfiqur Rahman, Cynthia Sawyez, Nica Borradaile, Rennian Wang. N-acetyl-L-cysteine treatment reduces beta-cell oxidative stress and pancreatic stellate cell activity in a high fat diet-induced diabetic mouse model. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.938680
17
Xiao-Mei Wang, Ze Dai, Dai-Jun Lu, Chao-Qun Bao, Nai-Bin Yang, Yu-Ping Zhou. Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation. World Journal of Gastroenterology 2025; 31(17): 105438 doi: 10.3748/wjg.v31.i17.105438
18
Tyler A. Shaw, Ragunath Singaravelu, Megan H. Powdrill, Jordan Nhan, Nadine Ahmed, Dennis Özcelik, John Paul Pezacki. MicroRNA-124 Regulates Fatty Acid and Triglyceride Homeostasis. iScience 2018; 10: 149 doi: 10.1016/j.isci.2018.11.028
19
Adnan Malik, Mahum Nadeem, Muhammad Imran Malik. Efficacy of elafibranor in patients with liver abnormalities especially non-alcoholic steatohepatitis: a systematic review and meta-analysis. Clinical Journal of Gastroenterology 2021; 14(6): 1579 doi: 10.1007/s12328-021-01491-7
20
Sadia Qamar Arain, Farah Naz Talpur, Naseem Aslam Channa, Muhammad Shahbaz Ali, Hassan Imran Afridi. Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0683-y
21
Jeongin Yoo, Jeong Min Lee, Ijin Joo, Dong Ho Lee, Jeong Hee Yoon, Hyo-Jin Kang, Su Joa Ahn. Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis. Ultrasonography 2020; 39(2): 121 doi: 10.14366/usg.19034
22
Zhaomin Liu, Chaogang Chen, Cheng Wang, Yaqian Wang, Minmin Li, Wenjing Pan. Extra-Thyroidal Impacts of Serum Iodine Concentrations During Early Pregnancy on Metabolic Profiles and Pregnancy Outcomes: Prospective Study Based on Huizhou Mother–Infant Cohort. Nutrients 2025; 17(10): 1626 doi: 10.3390/nu17101626
23
A. I. Ershova, D. O. Al Rashi, A. A. Ivanova, Yu. O. Aksenova, A. N. Meshkov. Secondary hyperlipidemias: etiology and pathogenesis. Russian Journal of Cardiology 2019; (5): 74 doi: 10.15829/1560-4071-2019-5-74-81
24
Ting-An Lin, Bo-Jun Ke, Shih-Cheng Cheng, Chun-Lin Lee. Red Quinoa Bran Extract Prevented Alcoholic Fatty Liver Disease via Increasing Antioxidative System and Repressing Fatty Acid Synthesis Factors in Mice Fed Alcohol Liquid Diet. Molecules 2021; 26(22): 6973 doi: 10.3390/molecules26226973
25
Debajit Maiti, Subrata Munan, Shweta Singh, Ranajit Das, Animesh Samanta, Subhabrata Sen. Light induced diversity-oriented synthesis (DOS) library of annulated indolizine fluorophores for imaging non-lysosomal lipid droplets (LDs). Journal of Materials Chemistry B 2023; 11(10): 2191 doi: 10.1039/D2TB02656B
26
Rofail S. Rakhmanov, Denis A. Narutdinov, Elena S. Bogomolova, Sergey A. Razgulin, Natalya N. Potekhina. Dyslipidemias among workers in the Arctic zone of Russia. Hygiene and sanitation 2024; 103(1): 38 doi: 10.47470/0016-9900-2024-103-1-38-43
27
I.I. Kovalchuk, A.Z. Pylypets, O.V. Prodanchuk, M.M. Tsap, Y.V. Lesyk, V.A. Kolotnytskyi. EFFECT OF SELENIUM CITRATE ON THE LIPID AND PHOSPHOLIPID COMPOSITION OF RABBIT BLOOD PLASMA. Fiziolohichnyĭ zhurnal 2025; 71(2): 58 doi: 10.15407/fz71.02.058
28
Pavel Kraml. Lipid-lowering therapy in selected specific groups of patients. Medicína pro praxi 2020; 17(3): 151 doi: 10.36290/med.2020.029
29
Veera Houttu, Julia Bouts, Yasaman Vali, Joost Daams, Aldo Grefhorst, Max Nieuwdorp, Adriaan G. Holleboom. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032164
30
Juan Ma, Zhongcao Wei, Qian Wang, Xiaolan Lu, Zhihua Zhou, Ruohan Li, Qiuai Shu, Yixin Liu, Jinhai Wang, Na Liu, Haitao Shi. Association of serum creatinine with hepatic steatosis and fibrosis: a cross-sectional study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02437-0
31
Jingxuan Zhou, Nanhai Zhang, Adil Aldhahrani, Mohamed Mohamed Soliman, Liebing Zhang, Feng Zhou. Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.956688
32
Maxim Jestin, Senta M. Kapnick, Tatyana N. Tarasenko, Cassidy T. Burke, Patricia M. Zerfas, Francisca Diaz, Hilary Vernon, Larry N. Singh, Ronald J. Sokol, Peter J. McGuire. Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity. Molecular Metabolism 2020; 37: 100981 doi: 10.1016/j.molmet.2020.100981
33
Ayobami Dare, Skylar D. King, Shi-You Chen. Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-58291-5
34
Grietje H. Prins, Theerut Luangmonkong, Dorenda Oosterhuis, Henricus A. M. Mutsaers, Frank J. Dekker, Peter Olinga. A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices. Nutrients 2019; 11(3): 507 doi: 10.3390/nu11030507
35
Dong-Woo Lim, Hyuck Kim, Seung-Jun Lee, Ga-Ram Yu, Jai-Eun Kim, Won-Hwan Park. Jwa Kum Whan Attenuates Nonalcoholic Fatty Liver Disease by Modulating Glucose Metabolism and the Insulin Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/4589810
36
Bojan Jorgačević, Danijela Vučević, Ivana Đuričić, Slađana Šobajić, Dušan Mladenović, Milena Vesković, Rada Ješić Vukićević, Tatjana Radosavljević. The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease. Chemistry and Physics of Lipids 2017; 204: 85 doi: 10.1016/j.chemphyslip.2017.03.009
37
João V. S. Guerra, Marieli M. G. Dias, Anna J. V. C. Brilhante, Maiara F. Terra, Marta García-Arévalo, Ana Carolina M. Figueira. Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases. Nutrients 2021; 13(8): 2830 doi: 10.3390/nu13082830
38
Ben van Ommen, Tim van den Broek, Iris de Hoogh, Marjan van Erk, Eugene van Someren, Tanja Rouhani-Rankouhi, Joshua C Anthony, Koen Hogenelst, Wilrike Pasman, André Boorsma, Suzan Wopereis. Systems biology of personalized nutrition. Nutrition Reviews 2017; 75(8): 579 doi: 10.1093/nutrit/nux029
39
Karen R. Jonscher, Kimberley D. Bruce. Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders. Advances in Experimental Medicine and Biology 2019; 1134: 33 doi: 10.1007/978-3-030-12668-1_3
40
Sang Hyun Ahn, Kang Pa Lee, Kibong Kim, Jun-Yong Choi, Sun-Young Park, Jin Hong Cheon. Dansameum regulates hepatic lipogenesis and inflammation in vitro and in vivo. Food Science and Biotechnology 2019; 28(5): 1543 doi: 10.1007/s10068-019-00579-8
41
A.A. Sangouni, A. Jamalzehi, M. Moradpour, H. Mozaffari-Khosravi. Nigella sativa Efficacy in Non-alcoholic Fatty Liver Disease: Mechanisms and Clinical Effects. Journal of Herbal Medicine 2024; 43: 100833 doi: 10.1016/j.hermed.2023.100833
42
Yeong-Seon Won, Seon-Gyeong Bak, Nisansala Chandimali, Eun Hyun Park, Hyung-Jin Lim, Hyuck Se Kwon, Sang-Ik Park, Seung Jae Lee. 7-MEGA™ inhibits adipogenesis in 3T3-L1 adipocytes and suppresses obesity in high-fat-diet-induced obese C57BL/6 mice. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02175-0
43
Anna Wiśniewska, Aneta Stachowicz, Katarzyna Kuś, Magdalena Ulatowska-Białas, Justyna Totoń-Żurańska, Anna Kiepura, Kamila Stachyra, Maciej Suski, Mariusz Gajda, Jacek Jawień, Rafał Olszanecki. Inhibition of Atherosclerosis and Liver Steatosis by Agmatine in Western Diet-Fed apoE-Knockout Mice Is Associated with Decrease in Hepatic De Novo Lipogenesis and Reduction in Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio. International Journal of Molecular Sciences 2021; 22(19): 10688 doi: 10.3390/ijms221910688
44
Fernanda Raya Tonetti, Alvaro Eguileor, Marko Mrdjen, Vai Pathak, Jared Travers, Laura E. Nagy, Cristina Llorente. Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease. Hepatology 2024; 80(6): 1342 doi: 10.1097/HEP.0000000000000924
45
Nannan Zhao, Shu Yang, Yimin Jia, Bo Sun, Bin He, Ruqian Zhao. Maternal betaine supplementation attenuates glucocorticoid-induced hepatic lipid accumulation through epigenetic modification in adult offspring rats. The Journal of Nutritional Biochemistry 2018; 54: 105 doi: 10.1016/j.jnutbio.2017.12.003
46
Abbas Ali Sangouni, Saeid Ghavamzadeh. A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(5): 2917 doi: 10.1016/j.dsx.2019.07.063
47
Changyudong Huang, Yiqiong Zhang, Yongjie Xu, Sijia Wei, Tingting Yang, Shuang Wang, Chengcheng Li, Hairong Lin, Xing Li, Shuyun Zhao, Liying Zhu, Wei Pan. Prepared radix polygoni multiflori and emodin alleviate lipid droplet accumulation in nonalcoholic fatty liver disease through MAPK signaling pathway inhibition. Aging 2024;  doi: 10.18632/aging.205485
48
Qiao Ren, Yao Tan, Guixiang Zhang, Yuzhao Dai, Lidan Yang, Yunmo Wu, He He, Jie Chen. Efficacy of Hypoglycemic Agents in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A Systematic Review and Network Meta‐Analysis. Journal of Evidence-Based Medicine 2025; 18(2) doi: 10.1111/jebm.70021
49
Patricia E. Molina. Mechanisms Involved in Disruption of Adipose Tissue Mass Resulting from Chronic Unhealthy Alcohol Consumption. Alcoholism: Clinical and Experimental Research 2016; 40(11): 2296 doi: 10.1111/acer.13219
50
Nanjiba Nawaz, Tyler Mistretta, Christian Karime, Jason Lewis, Emily Wolf. Cholestatic Drug-Induced Liver Injury in a Patient Taking High-Dose Niacin for Hyperlipidemia. Journal of Investigative Medicine High Impact Case Reports 2024; 12 doi: 10.1177/23247096231224349
51
Johanna Matilainen, Anne-Mari Mustonen, Kirsi Rilla, Reijo Käkelä, Sanna P. Sihvo, Petteri Nieminen. Orotic acid-treated hepatocellular carcinoma cells resist steatosis by modification of fatty acid metabolism. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01243-5
52
Shireen Mohammad, Sura Al Zoubi, Debora Collotta, Nadine Krieg, Bianka Wissuwa, Gustavo Ferreira Alves, Gareth S. D. Purvis, Giuseppe Danilo Norata, Andrea Baragetti, Alberico Luigi Catapano, Egle Solito, Elisabeth Zechendorf, Tobias Schürholz, Wilmar Correa-Vargas, Klaus Brandenburg, Sina M. Coldewey, Massimo Collino, Muhammad M. Yaqoob, Lukas Martin, Christoph Thiemermann. RETRACTED: A Synthetic Peptide Designed to Neutralize Lipopolysaccharides Attenuates Metaflammation and Diet-Induced Metabolic Derangements in Mice. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.701275
53
Alice Y. Chen-Liaw, Gabrielle Hammel, George Gomez. Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells. In Vitro Cellular & Developmental Biology - Animal 2017; 53(8): 721 doi: 10.1007/s11626-017-0181-y
54
Sang Jun Yoon, Jeong Seok Yu, Byeong Hyun Min, Haripriya Gupta, Sung-Min Won, Hee Jin Park, Sang Hak Han, Byung-Yong Kim, Kyung Hwan Kim, Byoung Kook Kim, Hyun Chae Joung, Tae-Sik Park, Young Lim Ham, Do Yup Lee, Ki Tae Suk. Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1129904
55
Peter B. Soeters, Peter W. de Leeuw. Reciprocal Translation Between Pathophysiology and Practice in Health and Disease. 2021; : 93 doi: 10.1016/B978-0-12-820205-0.00002-5
56
Fenghua Li, Yang Yang, Lili Yang, Kai Wang, Xing Zhang, Yunlong Zong, Yixin Ding, Changhong Wang, Li Zhang, Guang Ji. Resveratrol alleviates FFA and CCl4 induced apoptosis in HepG2 cells via restoring endoplasmic reticulum stress. Oncotarget 2017; 8(27): 43799 doi: 10.18632/oncotarget.16460
57
Willem van den Brink, Robbert Bloem, Adithya Ananth, Thiru Kanagasabapathi, Arjen Amelink, Jildau Bouwman, Gerwin Gelinck, Sjaak van Veen, Andre Boorsma, Suzan Wopereis. Digital Resilience Biomarkers for Personalized Health Maintenance and Disease Prevention. Frontiers in Digital Health 2021; 2 doi: 10.3389/fdgth.2020.614670
58
So Yeong Cheon, Juhyun Song. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation. Cell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00836-0
59
Jierui Liu, Qingan Fu, Ruolin Su, Rixiang Liu, Shisheng Wu, Ke Li, Jianhua Wu, Nuobei Zhang. Association between nontraditional lipid parameters and the risk of type 2 diabetes and prediabetes in patients with nonalcoholic fatty liver disease: from the national health and nutrition examination survey 2017–2020. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1460280
60
Jiuxiang Zhao, Hong Zou, Yanling Huo, Xiaoyi Wei, Yu Li. Emerging roles of selenium on metabolism and type 2 diabetes. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1027629
61
Weilei Yao, Tongxin Wang, Jun Xia, Juan Li, Xinhong Yu, Feiruo Huang. Dietary Garcinol Attenuates Hepatic Pyruvate and Triglyceride Accumulation by Inhibiting P300/CBP-Associated Factor in Mid-to-Late Pregnant Rats. The Journal of Nutrition 2020; 150(2): 231 doi: 10.1093/jn/nxz238
62
Yi-Huai He, Li-Li Ou, Jin-Lian Jiang, Yun-Fen Chen, Aikedaimu Abudukeremu, Yuan Xue, Mao-Yuan Mu, Wei-Wei Zhong, De-Lin Xu, Xuan-Yu Meng, Ya-Qun Guan. <i>Bletilla striata</i> polysaccharides alleviate metabolic dysfunction-associated steatotic liver disease through enhancing hepatocyte RelA/ HNF1α signaling. World Journal of Gastroenterology 2025; 31(4): 93179 doi: 10.3748/wjg.v31.i4.93179
63
Shulun Jiang, Di-an Fang, Dongpo Xu. Transcriptome analysis of Takifugu obscurus liver in response to acute retene exposure. Journal of Environmental Science and Health, Part A 2020; 55(10): 1188 doi: 10.1080/10934529.2020.1780852
64
Mimoza Gjela, Anders Askeland, Maiken Mellergaard, Asbjørn Mohr Drewes, Aase Handberg, Jens Brøndum Frøkjær. Intra-pancreatic fat deposition and its relation to obesity: a magnetic resonance imaging study. Scandinavian Journal of Gastroenterology 2024; 59(6): 742 doi: 10.1080/00365521.2024.2333365
65
Francisca S. Teixeira, Lígia L. Pimentel, Susana S. M. P. Vidigal, João Azevedo-Silva, Manuela E. Pintado, Luís M. Rodríguez-Alcalá. Differential Lipid Accumulation on HepG2 Cells Triggered by Palmitic and Linoleic Fatty Acids Exposure. Molecules 2023; 28(5): 2367 doi: 10.3390/molecules28052367
66
Igor V. Maev, Alexey O. Bueverov, Artem V. Volnukhin. Efficacy and Safety of a Fixed Combination of Glycyrrhizic Acid and Essential Phospholipids in Non-Alcoholic Fatty and Alcoholic Liver Disease: Results from Randomized Placebo-Controlled Trials. Annals of the Russian academy of medical sciences 2021; 76(6): 595 doi: 10.15690/vramn1576
67
Weining Xie, Shengxin Chen. A nomogram for estimating the probability of nonalcoholic fatty liver disease in a Chinese population. Medicine 2020; 99(48): e23049 doi: 10.1097/MD.0000000000023049
68
Shreya C Pal, Nahum Méndez-Sánchez. Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis. World Journal of Gastroenterology 2023; 29(25): 3999-4008 doi: 10.3748/wjg.v29.i25.3999
69
Abbas Ali Sangouni, Saeid Ghavamzadeh, Atena Jamalzehi. A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(3): 2260 doi: 10.1016/j.dsx.2019.05.013
70
Vesna Lukenda Zanko, Viktor Domislovic, Vladimir Trkulja, Irena Krznaric‐Zrnic, Tamara Turk‐Wensveen, Zeljko Krznaric, Tajana Filipec Kanizaj, Delfa Radic‐Kristo, Lidija Bilic‐Zulle, Lidija Orlic, Petra Dinjar‐Kujundzic, Goran Poropat, Davor Stimac, Goran Hauser, Ivana Mikolasevic. Vitamin D for treatment of non‐alcoholic fatty liver disease detected by transient elastography: A randomized, double‐blind, placebo‐controlled trial. Diabetes, Obesity and Metabolism 2020; 22(11): 2097 doi: 10.1111/dom.14129
71
Hee-Sook Lim, Joungyun Choi, Bora Lee, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo. Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver. Clinical Nutrition Research 2020; 9(3): 182 doi: 10.7762/cnr.2020.9.3.182
72
Swagata Majumdar, Deeya Roy Chowdhury, Bidhan Chandra Chakraborty, Abhijit Chowdhury, Simanti Datta, Soma Banerjee. MiR-451a attenuates hepatic steatosis and hepatitis C virus replication by targeting glycerol kinase. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06286-9
73
Liqing Jiang, Qian Wang, Yingsong Jiang, Dadi Peng, Kezhen Zong, Shan Li, Wenyuan Xie, Cheng Zhang, Kaili Li, Zhongjun Wu, Zuotian Huang. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer’s disease through machine learning algorithms. Clinica Chimica Acta 2024; 557: 117892 doi: 10.1016/j.cca.2024.117892
74
Yu-Yuan Li, Chuang-Yu Cao, You-lian Zhou, Yu-Qiang Nie, Jie Cao, Yong-Jian Zhou. The roles and interaction of FXR and PPARs in the pathogenesis of nonalcoholic fatty liver disease. Arab Journal of Gastroenterology 2020; 21(3): 162 doi: 10.1016/j.ajg.2020.04.018
75
José A Roque-Jiménez, Mario F Oviedo-Ojeda, Megan Whalin, Héctor A Lee-Rangel, Alejandro E Relling. Ewe early gestation supplementation with eicosapentaenoic and docosahexaenoic acids affects the liver, muscle, and adipose tissue fatty acid profile and liver mRNA expression in the offspring. Journal of Animal Science 2023; 101 doi: 10.1093/jas/skad144
76
De-Shan Ning, Yu-Ju Chen, Chien-Ju Lin, Ching-Chiung Wang, Hong-Wei Zhao, Kun-Teng Wang, Ming-Chung Lee, Lemmuel L. Tayo, Wan-Chun Chiu, Chiu-Li Yeh, Chia-Jung Lee. Hepatoprotective effect of botanical drug formula on high-fat diet-induced non-alcoholic fatty liver disease by inhibiting lipogenesis and promoting anti-oxidation. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1026912
77
Yuanshe Huang, Xiaodong Wang, Lai Zhang, Ke Zheng, Jie Xiong, Jing Li, Chunlei Cong, Zhaomiao Gong, Jingxin Mao, Lei Chen. Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/7888076
78
Xiaorui Yao, Fan Xia, Waijiao Tang, Chunxin Xiao, Miaoting Yang, Benjie Zhou. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats. Journal of Ethnopharmacology 2018; 212: 208 doi: 10.1016/j.jep.2017.09.016
79
Pratima Dibba, Rosann Cholankeril, Andrew A. Li, Meera Patel, Mariam Fayek, Christy Dibble, Nnenna Okpara, Autumn Hines, Aijaz Ahmed. Hepatitis C in Pregnancy. Diseases 2018; 6(2): 31 doi: 10.3390/diseases6020031
80
Umar Farooque, Ashok Kumar Lohano, Quratulain Dahri, Nazia Arain, FNU Farukhuddin, Chinmay Khadke, Febin Prince, Rizwan Farooque, Mostafa A Shehata, Muhammad Daim Bin Zafar. The Pattern of Dyslipidemia in Chronic Liver Disease Patients. Cureus 2021;  doi: 10.7759/cureus.13259
81
Ammu P. Nair, Deepika Kaushik, Ashwani Kumar, Jyoti Singh, Emel Oz, Avinash Sharma, Ali Jebreen, Charalampos Proestos, Fatih Oz, Mukul Kumar. Deciphering the Effect of Ginsenoside Rk3 on Gut Microbiota and Its Applications. The FASEB Journal 2025; 39(13) doi: 10.1096/fj.202501234RR
82
Kenneth Leung, Michael Quezada, Zhengshan Chen, Gary Kanel, Neil Kaplowitz. Niacin‐Induced Anicteric Microvesicular Steatotic Acute Liver Failure. Hepatology Communications 2018; 2(11): 1293 doi: 10.1002/hep4.1253
83
Milos Mihajlovic, Sybren De Boever, Andrés Tabernilla, Ellen Callewaert, Julen Sanz-Serrano, Anouk Verhoeven, Amy Maerten, Zenzi Rosseel, Elisabeth De Waele, Mathieu Vinken. Investigation of parenteral nutrition-induced hepatotoxicity using human liver spheroid co-cultures. Archives of Toxicology 2024; 98(9): 3109 doi: 10.1007/s00204-024-03773-8
84
Myoung Ki Cho, Min Ji Seo, Vinayak Juvekar, Jae Hyung Jo, Wontae Kim, Kyeong Sook Choi, Hwan Myung Kim. Screening of Drug-Induced Steatosis and Phospholipidosis Using Lipid Droplet-Selective Two-Photon Probes. Analytical Chemistry 2020; 92(16): 11223 doi: 10.1021/acs.analchem.0c01728
85
Luca Rappez, Mira Stadler, Sergio Triana, Rose Muthoni Gathungu, Katja Ovchinnikova, Prasad Phapale, Mathias Heikenwalder, Theodore Alexandrov. SpaceM reveals metabolic states of single cells. Nature Methods 2021; 18(7): 799 doi: 10.1038/s41592-021-01198-0
86
Kaye-Eileen Willard, Don P. Wilson, Elizabeth J. Jackson, Carol F. Kirkpatrick, Mary Katherine Cheeley, Dinesh K. Kalra. Lipidology: The time is now for specialty recognition. Journal of Clinical Lipidology 2025; 19(2): 197 doi: 10.1016/j.jacl.2024.11.002
87
Rihua Zhang, Jing Bao Kan, Shan Lu, Pei Tong, Jie Yang, Ling Xi, Xiubing Liang, Dongming Su, Dong Li, Yun Liu. S100A16-induced adipogenesis is associated with up-regulation of 11 β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Bioscience Reports 2019; 39(9) doi: 10.1042/BSR20182042
88
Jingyi Qiao, Hanwei Li, Chen Jinxiang, Yanmei Shi, Ning Li, Pingsheng Zhu, Sisen Zhang, Mingsan Miao. Mulberry fruit repairs alcoholic liver injury by modulating lipid metabolism and the expression of miR-155 and PPARα in rats. Functional & Integrative Genomics 2023; 23(3) doi: 10.1007/s10142-023-01131-y
89
Avishek Mandal. Cattle Diseases - Molecular and Biochemical Approach. Veterinary Medicine and Science 2023; 16 doi: 10.5772/intechopen.108151
90
Assim A. Alfadda, Abdulrahman M. Almaghamsi, Suphia Murad Sherbeeni, Adel N. Alqutub, Abdullah S. Aldosary, Arthur C. Isnani, Nasser Al-Daghri, Simon D. Taylor-Robinson, Rukhsana Gul. Alterations in circulating lipidomic profile in patients with type 2 diabetes with or without non-alcoholic fatty liver disease. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1030661
91
Xiao-qun Han, San-qing Xu, Jian-guo Lin. Curcumin Recovers Intracellular Lipid Droplet Formation Through Increasing Perilipin 5 Gene Expression in Activated Hepatic Stellate Cells In Vitro. Current Medical Science 2019; 39(5): 766 doi: 10.1007/s11596-019-2104-5
92
Reem Ghazali, Kosha J Mehta, SW Annie Bligh, Ihab Tewfik, Dahn Clemens, Vinood B Patel. High omega arachidonic acid/docosahexaenoic acid ratio induces mitochondrial dysfunction and altered lipid metabolism in human hepatoma cells. World Journal of Hepatology 2020; 12(3): 84-98 doi: 10.4254/wjh.v12.i3.84
93
Yu Matsumoto, Saya Fujita, Ayano Yamagishi, Tomomi Shirai, Yukie Maeda, Tsukasa Suzuki, Ken-ichi Kobayashi, Jun Inoue, Yuji Yamamoto. Brown Rice Inhibits Development of Nonalcoholic Fatty Liver Disease in Obese Zucker (fa/fa) Rats by Increasing Lipid Oxidation Via Activation of Retinoic Acid Synthesis. The Journal of Nutrition 2021; 151(9): 2705 doi: 10.1093/jn/nxab188
94
Mettle Brahma, Soumika Ghosal, Mulaka Maruthi, Suresh K. Kalangi. Receptor Endocytosis and Signalling in Health and Disease - Part A. Progress in Molecular Biology and Translational Science 2023; 194: 347 doi: 10.1016/bs.pmbts.2022.07.008
95
Ying Wang, Yao Zhu, Junxing Niu, Qiangqiang Deng, Shimeng Guo, Haowen Jiang, Zhaoliang Peng, Yaru Xue, Huige Peng, Lijiang Xuan, Guoyu Pan. A novel bile acid analog, A17, ameliorated non-alcoholic steatohepatitis in high-fat diet-fed hamsters. Toxicology and Applied Pharmacology 2020; 404: 115169 doi: 10.1016/j.taap.2020.115169
96
David Grünig, Urs Duthaler, Stephan Krähenbühl. Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00257
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345